Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03158688
Brief Title: Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. (CANDOR)

First Submitted : May 9, 2017
First Submitted that Met QC Criteria : May 16, 2017
First Posted : May 18, 2017

Last Update Submitted that Met QC Criteria : August 22, 2019
Last Update Posted : August 26, 2019 (Estimate)